Predicting Prostate Biopsy Result in Men With Prostate Specific Antigen 2.0 to 10.0 ng/ml Using an Investigational Prostate Cancer Methylation Assay
Predicting Prostate Biopsy Result in Men With Prostate Specific Antigen 2.0 to 10.0 ng/ml Using an Investigational Prostate Cancer Methylation Assay
- Research Article
36
- 10.1016/s0022-5347(05)63932-8
- Feb 1, 2003
- Journal of Urology
Prostate Specific Antigen and Human Glandular Kallikrein 2 in Early Detection of Prostate Cancer
- Research Article
56
- 10.1016/j.urology.2009.02.016
- Apr 17, 2009
- Urology
Critical Appraisal of Prostate-specific Antigen in Prostate Cancer Screening: 20 Years Later
- Research Article
161
- 10.1016/j.juro.2009.12.056
- Feb 19, 2010
- Journal of Urology
-2]Proenzyme Prostate Specific Antigen is More Accurate Than Total and Free Prostate Specific Antigen in Differentiating Prostate Cancer From Benign Disease in a Prospective Prostate Cancer Screening Study
- Research Article
335
- 10.1016/s0022-5347(05)67711-7
- Apr 1, 2000
- Journal of Urology
OPTIMAL PREDICTORS OF PROSTATE CANCER ON REPEAT PROSTATE BIOPSY: A PROSPECTIVE STUDY OF 1,051 MEN
- Research Article
499
- 10.1016/j.juro.2010.12.032
- Mar 17, 2011
- Journal of Urology
A Multicenter Study of [-2]Pro-Prostate Specific Antigen Combined With Prostate Specific Antigen and Free Prostate Specific Antigen for Prostate Cancer Detection in the 2.0 to 10.0 ng/ml Prostate Specific Antigen Range
- Research Article
10
- 10.1016/s0022-5347(05)00707-x
- Mar 2, 2006
- Journal of Urology
New Insights Into the Diagnostic Accuracy of Complexed and Total Prostate Specific Antigen Using Discordance Analysis Characteristics
- Research Article
146
- 10.1016/s0022-5347(05)66519-6
- Mar 1, 2001
- Journal of Urology
THE INCIDENCE OF PROSTATE CANCER IN A SCREENING POPULATION WITH A SERUM PROSTATE SPECIFIC ANTIGEN BETWEEN 2.5 AND 4.0 NG./ML.: RELATION TO BIOPSY STRATEGY
- Research Article
96
- 10.1016/s0022-5347(05)67986-4
- Jan 1, 2000
- Journal of Urology
EXAMINATION OF THE 3 MOLECULAR FORMS OF SERUM PROSTATE SPECIFIC ANTIGEN FOR DISTINGUISHING NEGATIVE FROM POSITIVE BIOPSY: RELATIONSHIP TO TRANSITION ZONE VOLUME
- Research Article
79
- 10.1016/j.juro.2011.04.065
- Jul 23, 2011
- Journal of Urology
Changes in Prostate Specific Antigen in Hypogonadal Men After 12 Months of Testosterone Replacement Therapy: Support for the Prostate Saturation Theory
- Research Article
451
- 10.1016/s0022-5347(05)66083-1
- Jul 1, 2001
- Journal of Urology
PROSTATE CANCER DIAGNOSIS USING A SATURATION NEEDLE BIOPSY TECHNIQUE AFTER PREVIOUS NEGATIVE SEXTANT BIOPSIES
- Research Article
232
- 10.1016/j.juro.2012.08.219
- Oct 8, 2012
- Journal of Urology
Clinical Utility of an Epigenetic Assay to Detect Occult Prostate Cancer in Histopathologically Negative Biopsies: Results of the MATLOC Study
- Research Article
54
- 10.1097/01.ju.0000165203.40973.0f
- Aug 1, 2005
- Journal of Urology
PREDICTORS OF SUBSEQUENT PROSTATE CANCER IN MEN WITH A PROSTATE SPECIFIC ANTIGEN OF 2.6 TO 4.0 NG/ML AND AN INITIALLY NEGATIVE BIOPSY
- Research Article
71
- 10.1097/01.ju.0000145883.01068.5f
- Jan 1, 2005
- Journal of Urology
ACCURACY OF PROSTATE WEIGHT ESTIMATION BY DIGITAL RECTAL EXAMINATION VERSUS TRANSRECTAL ULTRASONOGRAPHY
- Research Article
83
- 10.1016/j.juro.2015.01.126
- Apr 4, 2015
- Journal of Urology
Gleason 6 Prostate Cancer: Translating Biology into Population Health
- Research Article
172
- 10.1093/annonc/mdt208
- Oct 1, 2013
- Annals of Oncology
Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up